The Joint Corp. Closes Sale of 31 Corporate Clinics in Arizona and New Mexico and Acquires Regional Developer Rights in the Northwest Region
The Joint Corp (NASDAQ: JYNT) has completed a significant transaction involving the sale of 31 corporate-owned clinics in Arizona and New Mexico to Joint Ventures, LLC for $8.3 million in cash. As part of the deal, JYNT acquired regional developer rights in the Northwest region, which generated $855,000 in royalties and franchise fees over the 12 months ended March 31, 2025.
The acquired Northwest territory rights cover 46 existing franchised clinics and 30 sites for future development. Joint Ventures, one of JYNT's strongest franchisees, will grow to 96 clinics and has committed to opening 10 additional locations. The company expects this refranchising initiative to strengthen its business model, reduce commission obligations, and increase operating margins.
The Joint Corp (NASDAQ: JYNT) ha concluso una transazione importante con la vendita di 31 cliniche di proprietà aziendale in Arizona e New Mexico a Joint Ventures, LLC per 8,3 milioni di dollari in contanti. Nell'ambito dell'accordo, JYNT ha acquisito i diritti di sviluppo regionale nella regione del Northwest, che ha generato 855.000 dollari in royalties e commissioni di franchising nei 12 mesi terminati il 31 marzo 2025.
I diritti territoriali acquisiti nel Northwest coprono 46 cliniche in franchising esistenti e 30 siti per futuri sviluppi. Joint Ventures, uno dei franchisee più solidi di JYNT, crescerà fino a 96 cliniche e si è impegnata ad aprire 10 ulteriori sedi. L'azienda prevede che questa iniziativa di rifranchising rafforzerà il suo modello di business, ridurrà gli obblighi di commissione e aumenterà i margini operativi.
The Joint Corp (NASDAQ: JYNT) ha completado una transacción importante con la venta de 31 clínicas de propiedad corporativa en Arizona y Nuevo México a Joint Ventures, LLC por 8,3 millones de dólares en efectivo. Como parte del acuerdo, JYNT adquirió los derechos de desarrollo regional en la región del Noroeste, que generaron 855.000 dólares en regalías y tarifas de franquicia durante los 12 meses terminados el 31 de marzo de 2025.
Los derechos territoriales adquiridos en el Noroeste cubren 46 clínicas franquiciadas existentes y 30 sitios para desarrollo futuro. Joint Ventures, uno de los franquiciados más fuertes de JYNT, crecerá hasta 96 clínicas y se ha comprometido a abrir 10 ubicaciones adicionales. La compañía espera que esta iniciativa de refranquicia fortalezca su modelo de negocio, reduzca las obligaciones de comisión y aumente los márgenes operativos.
The Joint Corp (NASDAQ: JYNT)는 애리조나와 뉴멕시코에 위치한 31개의 회사 소유 클리닉을 Joint Ventures, LLC에 현금 830만 달러에 매각하는 중요한 거래를 완료했습니다. 이번 거래의 일환으로 JYNT는 2025년 3월 31일로 종료된 12개월 동안 855,000달러의 로열티 및 프랜차이즈 수수료를 창출한 노스웨스트 지역 개발 권리를 인수했습니다.
인수한 노스웨스트 지역 권리는 기존 프랜차이즈 클리닉 46곳과 향후 개발을 위한 30개 부지를 포함합니다. JYNT의 가장 강력한 프랜차이즈 중 하나인 Joint Ventures는 96개 클리닉으로 성장할 예정이며, 추가 10개 지점 개설을 약속했습니다. 회사는 이번 리프랜차이징 이니셔티브가 비즈니스 모델을 강화하고 커미션 부담을 줄이며 운영 마진을 높일 것으로 기대하고 있습니다.
The Joint Corp (NASDAQ : JYNT) a finalisé une transaction importante portant sur la vente de 31 cliniques détenues par l'entreprise en Arizona et au Nouveau-Mexique à Joint Ventures, LLC pour 8,3 millions de dollars en espèces. Dans le cadre de cet accord, JYNT a acquis les droits de développement régional dans la région du Nord-Ouest, qui ont généré 855 000 dollars de redevances et de frais de franchise au cours des 12 mois se terminant le 31 mars 2025.
Les droits territoriaux acquis dans le Nord-Ouest couvrent 46 cliniques franchisées existantes ainsi que 30 sites destinés à un développement futur. Joint Ventures, l'un des franchisés les plus solides de JYNT, passera à 96 cliniques et s'est engagé à ouvrir 10 emplacements supplémentaires. L'entreprise s'attend à ce que cette initiative de refranchisage renforce son modèle commercial, réduise ses obligations de commission et augmente ses marges opérationnelles.
The Joint Corp (NASDAQ: JYNT) hat eine bedeutende Transaktion abgeschlossen, bei der 31 firmeneigene Kliniken in Arizona und New Mexico für 8,3 Millionen US-Dollar in bar an Joint Ventures, LLC verkauft wurden. Im Rahmen des Deals erwarb JYNT die regionalen Entwicklungsrechte in der Nordwestregion, die in den 12 Monaten bis zum 31. März 2025 855.000 US-Dollar an Lizenzgebühren und Franchisegebühren generierten.
Die erworbenen Rechte für das Nordwest-Territorium umfassen 46 bestehende Franchise-Kliniken und 30 Standorte für zukünftige Entwicklungen. Joint Ventures, einer der stärksten Franchisenehmer von JYNT, wird auf 96 Kliniken wachsen und hat sich verpflichtet, 10 weitere Standorte zu eröffnen. Das Unternehmen erwartet, dass diese Re-Franchising-Initiative sein Geschäftsmodell stärkt, Provisionsverpflichtungen reduziert und die Betriebsmargen erhöht.
- Sale generates $8.3 million in cash, strengthening company's working capital
- Acquisition of Northwest RD rights eliminates $855,000 in annual commission obligations
- Strategic expansion with proven operator committing to 10 new clinics
- Simplified business model through refranchising to experienced operators
- Potential for increased operating margins through reduced commission structure
- Reduction in direct corporate clinic ownership and associated revenue
- Exposure to nationwide labor shortage in recruiting qualified chiropractors
- Increased operating expenses due to inflation pressures
- Disclosed material weaknesses in internal control over financial reporting
Insights
Joint Corp's $8.3M clinic sale plus acquisition of regional developer rights streamlines operations and improves margin potential.
The Joint Corp has executed a strategic restructuring through a dual transaction: selling 31 corporate-owned clinics for
The sale to Joint Ventures (described as one of their strongest franchisees) accomplishes several objectives. First, it simplifies the corporate structure by reducing direct clinic operation responsibilities. Second, it brings an immediate
The acquired Northwest regional developer rights cover 46 existing franchised clinics plus 30 future development sites. These rights generated
From a strategic perspective, this transaction accelerates The Joint's transformation toward a more franchise-focused business model. The reduced operational complexity combined with expanded working capital should allow management to focus resources on higher-return initiatives that strengthen their core franchise proposition. With existing franchisees expanding their investment (growing to 96 locations plus committing to 10 new openings), this serves as a validation of management's strategic direction and the underlying health of The Joint's business model.
- Proven Operator Grows to 96 Clinics and Commits to Open 10 Additional Clinics -
- Sale Price Included
SCOTTSDALE, Ariz., July 07, 2025 (GLOBE NEWSWIRE) -- The Joint Corp. (NASDAQ: JYNT), the nation's largest franchisor of chiropractic care through The Joint Chiropractic® network, closed the sale of 31 corporate owned and managed clinics and associated franchise licenses in Arizona and New Mexico to Joint Ventures, LLC in exchange for
“Our goal for the refranchising initiative is to strengthen and simplify our business, while ensuring our clinics go to proven franchise operators that can improve performance and grow within their regions,” said The Joint Corp.’s President, Chief Executive Officer and Director Sanjiv Razdan. “We are very happy that Joint Ventures, one of our strongest franchisees, is purchasing 31 clinics in Arizona and New Mexico. As part of the consideration for the clinics, we are acquiring Joint Ventures' regional developer rights for the Northwest region, covering 46 existing franchised clinics and 30 sites for future clinic development. By acquiring RD rights, we will reduce commission obligations and increase operating margin, as these clinics incurred
Forward-Looking Statements
This press release contains statements about future events and expectations that constitute forward-looking statements. Forward-looking statements are based on our beliefs, assumptions and expectations of industry trends, our future financial and operating performance and our growth plans, taking into account the information currently available to us. These statements are not statements of historical fact. Words such as, “anticipates,” “believes,” “continues,” “estimates,” “expects,” “goal,” “objectives,” “intends,” “may,” “opportunity,” “plans,” “potential,” “near-term,” “long-term,” “projections,” “assumptions,” “projects,” “guidance,” “forecasts,” “outlook,” “target,” “trends,” “should,” “could,” “would,” “will,” and similar expressions are intended to identify such forward-looking statements. Specific forward-looking statements made in this press release include, among others, our goal for the refranchising initiative to strengthen and simplify our business, while ensuring our clinics go to proven franchise operators that can improve performance and grow within their regions; our belief that by increasing their stake in The Joint, existing franchisees are validating our initiatives to strengthen the patient experience, drive revenue and reduce operational costs; our belief that by acquiring RD rights, we will reduce commission obligations, increase operating margin; and our expectation to deploy our expanding working capital to generate value for stockholders. Forward-looking statements involve risks and uncertainties that may cause our actual results to differ materially from the expectations of future results we express or imply in any forward-looking statements, and you should not place undue reliance on such statements. Factors that could contribute to these differences include, but are not limited to, our inability to identify and recruit enough qualified chiropractors and other personnel to staff our clinics, due in part to the nationwide labor shortage and an increase in operating expenses due to measures we may need to take to address such shortage; inflation, which has increased our costs and which could otherwise negatively impact our business; our failure to profitably operate company-owned or managed clinics; our failure to refranchise as planned; short-selling strategies and negative opinions posted on the internet, which could drive down the market price of our common stock and result in class action lawsuits; our failure to remediate future material weaknesses in our internal control over financial reporting, which could negatively impact our ability to accurately report our financial results, prevent fraud, or maintain investor confidence; and other factors described in our filings with the SEC, including in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2024 filed with the SEC on March 14, 2025 and subsequently filed current and quarterly reports. We qualify any forward-looking statements entirely by these cautionary factors. We assume no obligation to update or revise any forward-looking statements for any reason or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future. Comparisons of results for current and any prior periods are not intended to express any future trends or indications of future performance, unless expressed as such, and should only be viewed as historical data.
About The Joint Corp. (NASDAQ: JYNT)
The Joint Corp. (NASDAQ: JYNT) revolutionized access to chiropractic care when it introduced its retail healthcare business model in 2010. Today, it is the nation’s largest operator, manager and franchisor of chiropractic clinics through The Joint Chiropractic network. The company is making quality care convenient and affordable, while eliminating the need for insurance, for millions of patients seeking pain relief and ongoing wellness. With over 950 locations nationwide and more than 14 million patient visits annually, The Joint Chiropractic is a key leader in the chiropractic industry. The brand is consistently named to Franchise Times’ annual “Top 400” and “Fast & Serious” list of 40 smartest growing brands. Entrepreneur named The Joint “No. 1 in Chiropractic Services,” and is regularly ranked on the publication’s “Franchise 500,” the “Fastest-Growing Franchises,” the “Best of the Best” lists, as well as its “Top Franchise for Veterans” and “Top Brands for Multi-Unit Owners.” SUCCESS named the company as one of the “Top 50 Franchises” in 2024. The Joint Chiropractic is an innovative force, where healthcare meets retail. For more information, visit www.thejoint.com. To learn about franchise opportunities, visit www.thejointfranchise.com.
The Joint Business Structure
The Joint Corp. is a franchisor of clinics and an operator of clinics in certain states. In Arkansas, California, Colorado, District of Columbia, Florida, Illinois, Kansas, Kentucky, Maryland, Michigan, Minnesota, New Jersey, New York, North Carolina, Oregon, Pennsylvania, Rhode Island, South Dakota, Tennessee, Washington, West Virginia and Wyoming, The Joint Corp. and its franchisees provide management services to affiliated professional chiropractic practices.
Media Contact:
Margie Wojciechowski, The Joint Corp., margie.wojciechowski@thejoint.com
Investor Contact:
Kirsten Chapman, Alliance Advisors IR, 415-433-3777, thejointinvestor@allianceadvisors.com
